AstraZeneca announces that it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500m to support the enhanced manufacturing capability of a broader range of medicines including cancer treatments. This is part of the historic $50 billion investment announced in July 2025. The new facility will be located at …

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the successful completion of the analytical validation of a cheek swab collection method for testing patients for both clinical trial usage as well as future commercial application. This major step marks a …

The University of Virginia today celebrates a key milestone in the construction of the Paul and Diane Manning Institute of Biotechnology’s 350,000-square-foot facility at Fontaine Research Park with a “topping off” ceremony at which the final steel beam will be placed. “I am delighted to be one step closer to opening the Manning Institute’s state-of-the-art new facility and …

BUILT Biotechnologies, an emerging leader in DNA Manufacturing-as-a-Service, today announced its selection as an anchor company at the Commonwealth BioAccelerator, an initiative led by CvilleBioHub to strengthen Virginia’s biotechnology ecosystem. The relocation of BUILT’s headquarters to CvilleBioHub’s state-of-the-art facilities at North Fork Research Park positions the company to rapidly scale production in a new, next-generation …

In 2020, G2G Consulting launched the Shauna M. Sorrells Program to provide a $10,000 grant to a nonprofit that dedicates meaningful services and programs to women and children, especially women of color. Award winners have provided programming in breast cancer screening services, maternal health, housing, STEM education programs, adult literacy, domestic violence shelter, and career …

ATCC is excited to launch their 2025 Innovation Challenge, inviting researchers to explore bold, creative applications of their ThawReady™ Assay Ready Cells, an innovative line of products  designed to accelerate cell-based assays and eliminate the need for lengthy cell expansion and banking prior to starting bioassays, saving valuable time and money. Running through November 30, …

Serpin Pharma has entered a strategic partnership with Dogwood Therapeutics to develop and commercialize SP16, a first-in-class LRP1 agonist targeting chemotherapy-induced peripheral neuropathy (CIPN). SP16 IV, the intravenous formulation, has shown dual anti-inflammatory and neural repair effects in preclinical studies and will enter a Phase 1b trial in early 2026, fully funded by the National …

Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, announced today that it has received a $500,000 grant award from the Gates Foundation. This funding will support the deployment of Ceres’ wastewater biosecurity products to global health testing sites across Africa and India. Global biosecurity …

Eli Lilly and Company (NYSE: LLY) today announced that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County. The new site will be the company’s first dedicated, fully integrated active pharmaceutical ingredient (API) and drug product facility for Lilly’s emerging bioconjugate platform and monoclonal antibody portfolio. Earlier …

ATCC, the world’s premier biological materials management and standards organization, today announced that it has been granted a contract with Capra Biosciences, a Virginia-based biotech company focused on the cost-competitive production of petrochemical replacements using its modular bioreactor platform. ATCC is supporting a contract with Capra to work on the Defense Advanced Research Projects Agency’s …

RIVANNA®, developers of world-first imaging-based medical technologies, has been awarded a $2.21 million Small Business Innovation Research (SBIR) Direct to Phase II (R44) grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to develop an ultrasound guidance solution for pediatric lumbar punctures (LPs) on its Accuro® 3S platform. Lumbar punctures …

Cupron Performance Additives (Cupron) announced today the launch of an exclusive distribution agreement with Palmer Holland, leading North American distributor of specialty additives for the engineered materials marketplace. Palmer Holland will distribute Cupron’s copper-based antimicrobial and anti-odor technologies into plastics, films, foams, and polymeric systems throughout North America. The Cupron line effectively complements Palmer Holland’s …

The Virginia Biotechnology Research Partnership Authority (doing business as Activation Capital) announced today that it has appointed Michael Steele as president and chief executive officer. Steele succeeds Robert Ward, who has served as interim CEO since July 2024 during a period of rapid growth for the life sciences ecosystem development organization. Steele comes to Activation …

Danforth Advisors LLC, today announced the acquisition of PharmaDirections, Inc., a full-spectrum development partner to life science companies, expanding its integrated capabilities from discovery through commercialization. Founded in 2003, PharmaDirections was a pioneer of the virtual drug development model. The company brings veteran program leaders and more than 150 specialists to support strategic planning and …

A study published this month in The BMJ (British Medical Journal) analyzed the use of optical sensor technology from ivWatch, the U.S.-based IV safety company, in the early detection of peripheral intravenous infiltration or extravasation (PIVIE) events in neonates. Presenting a comparative evaluation between conventional observational methods and continuous sensor-based monitoring, the study offers insights …

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to RLS-0071 (pegtarazimod) for the treatment of Graft-versus-Host Disease (GvHD). The Orphan Drug Designation …

In a transformative move to accelerate global access to life-restoring technologies, LifeNet Health, a world leader in regenerative medicine, has acquired HCM Medical, a Netherlands-based contract manufacturing organization (CMO) known for its pioneering biologics and tissue-processing capabilities. This strategic acquisition addresses a critical challenge in modern healthcare: ensuring timely, equitable access to breakthrough regenerative therapies for …

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the appointment of its new Chief Financial Officer as the Company advances its lead product candidate, QRX003, through pivotal clinical studies and prepares for potential commercialization. Quoin has appointed Sally Lawlor, …

August 13, 2025  – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2.4 million in grants to three life and bioscience projects in the Commonwealth of Virginia through a highly-competitive Grant Round 18.   “The bioscience ecosystem in Virginia is vibrant, with university researchers, …

Governor Youngkin announces new Lab-to-Launch initiative to unlock innovation in Virginia by accelerating university research commercialization and technology transfer. Developed through a bold statewide collaboration between Virginia Innovation Partnership Corporation (VIPC) and Virginia’s six R1 research university partners – George Mason University, Old Dominion University, the University of Virginia, Virginia Commonwealth University, Virginia Tech, William …

CvilleBioHub will expand the Commonwealth BioAccelerator and state-of-the-art facilities at the North Fork Discovery Park. The expansion is powered by a transformational $15 million investment from the Commonwealth of Virginia and the University of Virginia. This funding establishes a commitment to life sciences entrepreneurship and commercialization in Virginia and signals a major leap forward for …

Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced it received the Prototype Innovation award by the Medical CBRN Defense Consortium (MCDC) in recognition of its successful prototype development of the Rapid Opioid Countermeasure System (ROCS) (Naloxone HCl Injection, USP) antidote for ultra-potent weaponized opioids. This is the first time the …

For the third consecutive year, the BioHealth Capital Region (BHCR), encompassing Maryland, Virginia, and Washington, D.C., has earned a Top 3 position in the highly regarded “Top 10 U.S. Biopharma Clusters” list by Genetic Engineering & Biotechnology News (GEN). Compiled annually by GEN Senior Business Editor Alex Philippidis, this national ranking evaluates five key indicators …

Roanoke College and Virginia Western Community College are joining together to begin a new biotechnology bachelor’s degree program, according to officials. The program is expected to begin this fall. Officials say the development of the four-year program is a direct response to the region’s need for a strategic workforce that can help elevate the Roanoke …